dm+d

412554007

Articles

Safety in Lactation: Some other antibacterials

4 November 2020Monitor infant for gastro-intestinal disturbances and oral candida infection, especially if used for prolonged periods or in high doses, although these effects are unlikely to…
Search Articles

Medicine Compliance Aid Stability

Targaxan/XifaxantaNorgine Ltd

Norgine Ltd
Targaxan/Xifaxanta
Tablets 200mg, 550mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Hygroscopic Store in airtight container, protect from light. Maximum 7 days in MCA.
30 March 2015

Lactation Safety Information

Yes
No published evidence of safety
Not absorbed from the infant's GI tract
Unlikely to cause adverse effects in the breastfed infant
22 September 2020